Remimazolam Attenuates Neurological Injury After TBI: A Potential Role of α7nAChR-Associated Mitophagy Enhancement and Pyroptosis Suppression in BV2 Cells
Drug Design, Development and Therapy · 2026-08 · Volume 20 · 1-21
DOI: 10.2147/dddt.s613828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-08. Verfasst von Longfei Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Mitophagy, Pyroptosis, Brain Injuries, Traumatic. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
ORCID-Profile: Bing Zhang
Zitieren
APA
Li, L., Bao, R., Meng, Y., Li, X., Li, H., Duan, P., Bi, Y., Chen, J., Xing, Y., Luo, L., Yu, Y., Yu, M., Cui, M., & Zhang, B. (2026). Remimazolam Attenuates Neurological Injury After TBI: A Potential Role of α7nAChR-Associated Mitophagy Enhancement and Pyroptosis Suppression in BV2 Cells. Drug Design, Development and Therapy, Volume 20, 1-21. https://doi.org/10.2147/dddt.s613828
Vancouver
Li L, Bao R, Meng Y, Li X, Li H, Duan P, et al. Remimazolam Attenuates Neurological Injury After TBI: A Potential Role of α7nAChR-Associated Mitophagy Enhancement and Pyroptosis Suppression in BV2 Cells. Drug Design, Development and Therapy. 2026;Volume 20:1-21. doi:10.2147/dddt.s613828
BibTeX
@article{Li2026,
author = {Li, Longfei and Bao, Rugan and Meng, Yao and Li, Xiaoyan and Li, Hangbing and Duan, Pengyu and Bi, Yonghong and Chen, Jiali and Xing, Yuling and Luo, Lan and Yu, Yang and Yu, Miao and Cui, Muyan and Zhang, Bing},
title = {Remimazolam Attenuates Neurological Injury After TBI: A Potential Role of α7nAChR-Associated Mitophagy Enhancement and Pyroptosis Suppression in BV2 Cells},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--21},
doi = {10.2147/dddt.s613828}
}
EUVIMED